---
schema_version: "secwatch.filing_event.v1"
accession: "0001753926-23-001555"
form_type: "8-K"
ticker: "LIPO"
cik: "0001347242"
company_name: "LIPELLA PHARMACEUTICALS INC."
filed_at: "2023-11-28T23:59:59+00:00"
generated_at: "2026-06-07T20:54:06.755382+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Lipella receives Nasdaq deficiency notice for potential minimum equity violation

## Summary
- Received Nasdaq notice on Nov 21, 2023, for failure to maintain minimum $2.5M stockholders' equity as of Sep 30, 2023.
- No immediate effect on listing of LIPO common stock; continues to trade normally.
- Company evaluating measures to regain compliance but cannot assure success.
- If not remedied, Nasdaq may delist the stock; compliance deadline not specified.

## SEC filing metadata
- accession: 0001753926-23-001555
- form_type: 8-K
- ticker: LIPO
- cik: 0001347242
- company_name: LIPELLA PHARMACEUTICALS INC.
- filed_at: 2023-11-28T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1347242/000175392623001555/0001753926-23-001555-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1347242/000175392623001555/g083873_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001753926-23-001555
- JSON: https://secwatch.observer/filing/0001753926-23-001555.json
- Plain text: https://secwatch.observer/filing/0001753926-23-001555.txt

## Key facts
- Listing & Compliance Notices
  LIPELLA PHARMACEUTICALS INC. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: stockholders equity
  - Rules: 5550(b)(1)
  source text: November 21, 2023, Lipella Pharmaceuticals Inc. (the “Company”) received notice (the “Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) that the Company may have failed to maintain a required minimum of $2,500,000 in stockholders’ equity for continued listing, as required under Nasdaq Listing Rule 5550(b)(1) (the “Minimum Equity Rule”), based on the financial results reported in the Company’s Form 10-Q for the period ended September 30, 2023, as filed with the SEC on November 14, 2023. The Notice has no immediate effect on the listing of the Company’s common stock, par value $0.0001 per sha
  evidence_url: https://www.sec.gov/Archives/edgar/data/1347242/000175392623001555/0001753926-23-001555-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.